Syrups are easy to administer to older infants who may like the slightly sweet taste. Younger infants could be given effervescent tablets that dissolve in water. The water can be administered to the baby through a dropper syringe. Ideally, a baby should get relief from reflux and GERD within two weeks from the day Zantac was first administered. However, some may experience a few long-term side-effects of using the medicine. However, if the baby is regularly given Zantac or if there is an overdose of the medication, then the baby runs the risk of the following long-term side-effects:.
If your baby continues to spit up despite using Zantac, then take him to the doctor immediately. This could indicate some other underlying condition or infantile diseases such as pyloric stenosis that causes the baby to spit up Get your baby checked by a pediatrician in case of chronic spit ups that do not stop even with ranitidine. Zantac is different from Prilosec and Prevacid.
Prilosec is the brand name for the generic compound called omeprazole and Prevacid is the brand name for lansoprazole. Both omeprazole and lansoprazole belong to the compound group called proton-pump inhibitors, also used for treating acid reflux 9 , while ranitidine Zantac is an H2 blocker. They act differently.
There is no evidence that Zantac can provide babies relief from excessive gas. It may help ease the gas caused by acid reflux, but it does not treat gas directly. Ranitidine is less likely to cause serious side-effects that have a long-term effect on the baby.
Experts state that Zantac is safer than alternative medicines, but more research is needed to learn its true effects. For the safety of your infant, use Zantac only as and when prescribed by the pediatrician. Zantac belongs to a class of drugs known as histamine-2 H2 blockers, which works by reducing the production of stomach acid in the body.
Zantac is a brand name for the generic drug, ranitidine, which is commonly prescribed for the treatment of heartburn, gastroesophageal reflux disease GERD , ulcers, and related health conditions. Zantac ranitidine is available in both tablet and syrup form, but is generally prescribed to babies in the form of an oral syrup for severe reflux issues.
All prescription drugs in the United States are required to undergo rigorous evaluation and testing to determine drug safety before they can be prescribed to patients. Less is known, however, about the side effects of drugs like Zantac in babies, who can react to drugs differently than adults observed in clinical drug trials. According to medical experts, side effects of Zantac ranitidine in babies may include:. Reflux issues are very common in babies and are expected to improve in time through natural development.
Despite the widespread prescribing of Zantac and ranitidine to babies, multiple studies have indicated that there are several potential risks and dangers of treating babies with anti-reflux drugs.
The longer a baby is treated with a drug like Zantac, the greater the risk. According to research on the effects of Zantac in newborns, potential dangers of giving Zantac to babies include increased risk for:.
Evidence of these potential dangers has been known for years. However, more recently, there has been a new wave of concern among parents of babies who have taken ranitidine due to major recalls of Zantac and ranitidine products. Since September , over a dozen pharmaceutical manufacturers have issued recalls of their Zantac and ranitidine products after they were found to contain toxic amounts of NDMA.
This chemical has been linked to several types of cancer and poses the greatest danger to individuals who have been taking ranitidine for months or years on a regular basis. Stores and pharmacies such as CVS Pharmacy, Target, and Walgreens have also pulled name-brand and generic Zantac products from their shelves to prevent further exposure to this cancerous chemical.
The U. Food and Drug Administration FDA released a statement on September 13, alerting doctors and patients of a discovered contaminant—a carcinogen known as NDMA—in certain Zantac and ranitidine products. This discovery was made by the independent pharmaceutical research company, Valisure, which detected unsafe levels of NDMA in ranitidine during routine testing.
Explaining your workings and logic to another member of staff can be enough to identify an error that may otherwise have been missed. Do not rely on the doctor to calculate the correct dose; you must be satisfied with the clinical appropriateness of all medicines that you dispense. If the dose on the prescription is not clear you should contact the prescriber to confirm.
If the prescriber cannot be contacted, consider what other options are available to confirm the correct dose. For example, contact the pharmacy department in the hospital where it was first prescribed or another doctor in the practice if it was initiated by a GP. Regulation 7 of the Medicinal Products Prescription and Control of Supply Regulations , as amended, sets out the requirements for a legally valid prescription. It is a legal requirement for the prescription to specify the age of the patient if they are under 12 years old.
If this information is omitted, the pharmacist can still dispense the prescription but they must exercise due diligence and care, and be satisfied that it is safe to do so. The appropriate dose of ranitidine for an infant will often be a fraction of a millilitre. It is important to highlight this to the parent or carer and to supply an oral syringe that can accurately measure the correct volume. The pharmacist must be mindful that the shelf life of Zantac liquid once it is open is 28 days and to highlight this to the parent or carer.
0コメント